NASDAQ
No price data available for this timeframe.
Avanos Medical, Inc. (AVNS) has a price/fcf ratio of 12.09x as of Monday, May 25, 2026. This represents a 60.78% decrease compared to its 12-month average of 30.83x. The price-to-free-cash-flow ratio measures a stock's price relative to its free cash flow per share, reflecting how efficiently a company generates cash.